The acquisition of the site from the Swiss pharmaceutical giant Novartis AG shows the confidence of German biotechnology in the experimental vaccine that is emerging in collaboration with its American wife Pfizer Inc and Shanghai Fosun Pharmaceutical Group Co. of China in the extension of existing sites, such as he had done it. planned, CEO Ugur Sahin said in an interview Wednesday night.
“Especially in the first part of 2021, we can get more doses than expected,” Sahin said.
BioNTech’s vaccine candidate and rivals are making their way through clinical studies amid intense public scrutiny and, in some countries, political promises in the United States, Paul Mango, one of the leaders of the administration’s Covid-19 vaccination program, said Wednesday that each and every American can be vaccinated until the end of March.
BioNTech and Pfizer will send a hundred million doses of vaccine this year, enough for another 50 million people to get a two-dose vaccine, and with this source already distributed among several governments, it would not be enough to dominate the United States. Sahin said. Partners expect to download initial knowledge of a 44,000-person exam next month to show if the vaccine is working.
Providing China
Acceleration to completion of production capacity will take some time. The new site will be to manufacture 250 million doses of your vaccine in the first part of next year, and then up to 750 million doses consistent with the year once it is completely incompatible with Injections will be introduced to the Chinese market and other countries around the world. Pfizer will also produce the vaccine in the United States and Europe.
Together, Pfizer and BioNTech had first stated that they could manufacture more than 1. 3 billion doses of vaccine by the end of next year. Today’s production agreement will increase its joint capacity by at least three hundred million doses according to the year, Mr. . Sahin.
BioNTech said it planned to conclude the agreement for the Marburg site, north of Frankfurt, in the fourth quarter, but revealed the monetary terms.
Click here to read that Mint ePapermint is now on Telegram. Join the mint channel in your telegram and informed
Log in to our to save your favorites. It’ll only take a moment.
Your query has expired, reconnect.
You are now subscribed to our newsletters. If you can’t find any email from us, check your spam folder